AU2769689A – Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a B-blocker antihypertensive agent
– Google Patents
AU2769689A – Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a B-blocker antihypertensive agent
– Google Patents
Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a B-blocker antihypertensive agent
Info
Publication number
AU2769689A
AU2769689A
AU27696/89A
AU2769689A
AU2769689A
AU 2769689 A
AU2769689 A
AU 2769689A
AU 27696/89 A
AU27696/89 A
AU 27696/89A
AU 2769689 A
AU2769689 A
AU 2769689A
AU 2769689 A
AU2769689 A
AU 2769689A
Authority
AU
Australia
Prior art keywords
hypertension
antihypertensive agent
potassium channel
treatment
pharmaceutical preparation
Prior art date
1988-01-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU27696/89A
Other versions
AU614008B2
(en
Inventor
Robin Edwin Buckingham
John Morris Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1988-01-06
Filing date
1989-01-04
Publication date
1989-07-06
Family has litigation
First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=10629550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2769689(A)
“Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
1989-01-04
Application filed by Beecham Group PLC
filed
Critical
Beecham Group PLC
1989-07-06
Publication of AU2769689A
publication
Critical
patent/AU2769689A/en
1991-08-15
Application granted
granted
Critical
1991-08-15
Publication of AU614008B2
publication
Critical
patent/AU614008B2/en
2009-01-04
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 – A61K41/00
A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/12—Antihypertensives
Abstract
A pharmaceutical product comprising a potassium channel activator antihypertensive agent and a beta -blocker antihypertensive agent as a combined preparation for simultaneous, separate or sequential use in therapy of hypertension.
AU27696/89A
1988-01-06
1989-01-04
Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a b-blocker antihypertensive agent
Ceased
AU614008B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
GB888800199A
GB8800199D0
(en)
1988-01-06
1988-01-06
Pharmaceutical preparation
GB8800199
1988-01-06
Publications (2)
Publication Number
Publication Date
AU2769689A
true
AU2769689A
(en)
1989-07-06
AU614008B2
AU614008B2
(en)
1991-08-15
Family
ID=10629550
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU27696/89A
Ceased
AU614008B2
(en)
1988-01-06
1989-01-04
Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a b-blocker antihypertensive agent
Country Status (15)
Country
Link
US
(1)
US5032591A
(en)
EP
(1)
EP0323745B1
(en)
JP
(1)
JPH01224316A
(en)
KR
(1)
KR890011591A
(en)
AT
(1)
ATE83375T1
(en)
AU
(1)
AU614008B2
(en)
CA
(1)
CA1317228C
(en)
DE
(1)
DE3876773T2
(en)
DK
(1)
DK2689A
(en)
ES
(1)
ES2042776T3
(en)
GB
(1)
GB8800199D0
(en)
GR
(1)
GR3006857T3
(en)
NZ
(1)
NZ227518A
(en)
PT
(1)
PT89388B
(en)
ZA
(1)
ZA8944B
(en)
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU642961B2
(en)
*
1990-02-13
1993-11-04
Merck Patent Gesellschaft Mit Beschrankter Haftung
Pharmaceutical composition
US5552443A
(en)
*
1990-08-30
1996-09-03
Oregon Health Sciences University
Substituted amidines having high binding to the sigma receptor and the use thereof
Families Citing this family (21)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
EP0633256A1
(en)
*
1988-12-13
1995-01-11
Beecham Group Plc
Benzopyran and related compounds
FR2645021A1
(en)
*
1989-03-30
1990-10-05
Sanofi Sa
USE OF A POTASSIC AGONIST IN THE TREATMENT OF GLAUCOMA
FR2653662B1
(en)
*
1989-10-31
1994-05-13
Rhone Poulenc Sante
APPLICATION OF N-METHYL (PYRIDYL-3) -2 TETRAHYDROTHIOPYRANNE-CARBOTHIOAMIDE-2-OXIDE-1 TO THE PREPARATION OF MEDICINES FOR THE TREATMENT OF CORONARY INSUFFICIENCY.
FR2657872B2
(en)
*
1989-11-06
1992-06-12
Sanofi Sa
AMIDINO-4 CHROMAN DERIVATIVE, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
TW224941B
(en)
*
1989-11-08
1994-06-11
Yamanouchi Pharma Co Ltd
US5643921A
(en)
*
1990-09-26
1997-07-01
E.R. Squibb & Sons, Inc.
Cardiopulmonary bypass and organ transplant using a potassium channel activator
GB9124754D0
(en)
*
1991-11-21
1992-01-15
Smithkline Beecham Plc
Pharmaceuticals
GB9807779D0
(en)
1998-04-09
1998-06-10
Ciba Geigy Ag
Organic compounds
US6417207B1
(en)
1999-05-12
2002-07-09
Nitromed, Inc.
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US20050089559A1
(en)
*
2003-10-23
2005-04-28
Istvan Szelenyi
Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
JP2008523145A
(en)
*
2004-12-13
2008-07-03
イーライ リリー アンド カンパニー
Spiro derivatives as lipoxygenase inhibitors
US7960436B2
(en)
*
2006-06-05
2011-06-14
Valeant Pharmaceuticals International
Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US20080045534A1
(en)
*
2006-08-18
2008-02-21
Valeant Pharmaceuticals North America
Derivatives of 1,3-diamino benzene as potassium channel modulators
BRPI0716715B1
(en)
*
2006-08-23
2021-07-06
Xenon Pharmaceuticals, Inc
4-(N-AZACICLOALKYL) DERIVATIVES AS POTASSIUM CHANNEL MODULATORS, THEIR USES, PRODUCT, COMPOSITION, TABLET AND CAPSULE
US8993593B2
(en)
*
2006-08-23
2015-03-31
Valeant Pharmaceuticals International
N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2
(en)
*
2006-10-10
2014-05-13
Valeant Pharmaceuticals International
N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
CA2670966A1
(en)
*
2006-11-28
2008-06-05
Valeant Pharmaceuticals International
1,4 diamino bicyclic retigabine analogues as potassium channel modulators
US20080207073A1
(en)
*
2007-02-22
2008-08-28
David Michael Jones
Coated multi-purpose fabric
US8367684B2
(en)
*
2007-06-13
2013-02-05
Valeant Pharmaceuticals International
Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2
(en)
2007-08-01
2013-10-22
Valeant Pharmaceuticals International
Naphthyridine derivatives as potassium channel modulators
US7786146B2
(en)
*
2007-08-13
2010-08-31
Valeant Pharmaceuticals International
Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
Family Cites Families (25)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB1489879A
(en)
*
1974-12-20
1977-10-26
Leo Pharm Prod Ltd
N’-cyano-n’-3-pyridylguanidines
ATE23718T1
(en)
*
1981-09-25
1986-12-15
Beecham Group Plc
BENZOPYRAN COMPOUNDS WITH PHARMACEUTICAL ACTIVITY.
DE3364145D1
(en)
*
1982-04-08
1986-07-24
Beecham Group Plc
ANTI-HYPERTENSIVE BENZOPYRANOLS
EP0093535B1
(en)
*
1982-04-28
1986-12-30
Beecham Group Plc
Novel chromenes and chromans
EP0095316B1
(en)
*
1982-05-21
1986-12-03
Beecham Group Plc
Pharmaceutically active aminobenzopyrans
EP0107423B1
(en)
*
1982-10-19
1986-07-23
Beecham Group Plc
Novel chromans and chromenes
GB8308063D0
(en)
*
1983-03-24
1983-05-05
Beecham Group Plc
Active compounds
GB8308064D0
(en)
*
1983-03-24
1983-05-05
Beecham Group Plc
Active compounds
DE3479726D1
(en)
*
1983-05-18
1989-10-19
Beecham Group Plc
BENZOPYRAN DERIVATIVES.
DE3486354T2
(en)
*
1983-05-18
1995-03-30
Beecham Group Plc
Chromium and chromium derivatives.
GB8313679D0
(en)
*
1983-05-18
1983-06-22
Beecham Group Plc
Active compounds
EP0139992B1
(en)
*
1983-09-01
1988-12-28
Beecham Group Plc
Chromanol derivatives
EP0138134B1
(en)
*
1983-10-13
1989-04-19
Beecham Group Plc
Chroman derivatives
GB8419516D0
(en)
*
1984-07-31
1984-09-05
Beecham Group Plc
Treatment
GB8419515D0
(en)
*
1984-07-31
1984-09-05
Beecham Group Plc
Treatment
GB8513369D0
(en)
*
1985-05-28
1985-07-03
Beecham Group Plc
Treatment
EP0205292B1
(en)
*
1985-06-08
1991-11-06
Beecham Group Plc
Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
GB8521857D0
(en)
*
1985-09-03
1985-10-09
Beecham Group Plc
Active compounds
PT84806B
(en)
*
1986-05-03
1989-12-29
Beecham Group Plc
PROCESS FOR THE PREPARATION OF BENZOPYRANES
GB8613786D0
(en)
*
1986-06-06
1986-07-09
Beecham Group Plc
Active compounds
GB8625185D0
(en)
*
1986-10-21
1986-11-26
Beecham Group Plc
Active compounds
ATE71535T1
(en)
*
1986-12-06
1992-02-15
Beecham Group Plc
PHARMACEUTICAL PREPARATIONS.
DE3726261A1
(en)
*
1986-12-23
1988-07-07
Merck Patent Gmbh
CHROME DERIVATIVES
EP0277611B1
(en)
*
1987-02-04
1993-06-16
Hoechst Aktiengesellschaft
Alkyl-substituted n-benzopyranyl lactames, process for their preparation, their use and pharmaceutical preparations on the basis of these compounds
DE3703227A1
(en)
*
1987-02-04
1988-08-18
Hoechst Ag
SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS
1988
1988-01-06
GB
GB888800199A
patent/GB8800199D0/en
active
Pending
1988-12-23
ES
ES88312287T
patent/ES2042776T3/en
not_active
Expired – Lifetime
1988-12-23
AT
AT88312287T
patent/ATE83375T1/en
active
1988-12-23
EP
EP88312287A
patent/EP0323745B1/en
not_active
Expired – Lifetime
1988-12-23
DE
DE8888312287T
patent/DE3876773T2/en
not_active
Revoked
1989
1989-01-04
CA
CA000587532A
patent/CA1317228C/en
not_active
Expired – Fee Related
1989-01-04
US
US07/293,209
patent/US5032591A/en
not_active
Expired – Fee Related
1989-01-04
AU
AU27696/89A
patent/AU614008B2/en
not_active
Ceased
1989-01-04
PT
PT89388A
patent/PT89388B/en
not_active
IP Right Cessation
1989-01-04
DK
DK002689A
patent/DK2689A/en
not_active
Application Discontinuation
1989-01-04
ZA
ZA8944A
patent/ZA8944B/en
unknown
1989-01-05
JP
JP64000827A
patent/JPH01224316A/en
active
Pending
1989-01-05
KR
KR1019890000134A
patent/KR890011591A/en
not_active
Application Discontinuation
1989-01-05
NZ
NZ227518A
patent/NZ227518A/en
unknown
1993
1993-01-21
GR
GR930400109T
patent/GR3006857T3/el
unknown
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU642961B2
(en)
*
1990-02-13
1993-11-04
Merck Patent Gesellschaft Mit Beschrankter Haftung
Pharmaceutical composition
US5552443A
(en)
*
1990-08-30
1996-09-03
Oregon Health Sciences University
Substituted amidines having high binding to the sigma receptor and the use thereof
Also Published As
Publication number
Publication date
EP0323745A3
(en)
1990-03-21
ES2042776T3
(en)
1993-12-16
KR890011591A
(en)
1989-08-21
DK2689A
(en)
1989-07-07
DE3876773T2
(en)
1993-04-29
EP0323745A2
(en)
1989-07-12
PT89388B
(en)
1993-09-30
DK2689D0
(en)
1989-01-04
EP0323745B1
(en)
1992-12-16
ATE83375T1
(en)
1993-01-15
NZ227518A
(en)
1991-08-27
ZA8944B
(en)
1990-09-26
JPH01224316A
(en)
1989-09-07
US5032591A
(en)
1991-07-16
DE3876773D1
(en)
1993-01-28
GB8800199D0
(en)
1988-02-10
CA1317228C
(en)
1993-05-04
PT89388A
(en)
1990-02-08
GR3006857T3
(en)
1993-06-30
AU614008B2
(en)
1991-08-15
Similar Documents
Publication
Publication Date
Title
AU2769689A
(en)
1989-07-06
Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a B-blocker antihypertensive agent
AU649605B2
(en)
1994-06-02
Retinal, derivatives and their therapeutic use
AU623512B2
(en)
1992-05-14
Phenyl pyrimidone derivatives, processes for their preparation, and their use therapeutic agents
AU3074289A
(en)
1989-09-28
2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents
AU6256996A
(en)
1996-12-30
Use of vitamin D4 derivatives for treating skin disorders
AU6806487A
(en)
1987-07-30
Tissue plasminogen activator
AU7597794A
(en)
1995-05-11
Soluble interferon alpha-receptor, its preparation and use
AU7313896A
(en)
1997-05-15
Pharmaceutical composition containing an activin or inhibin stimulator
AU8209987A
(en)
1988-06-09
Hypertension treatment using K+ channel activator and ace inhibitor agents
ZA877901B
(en)
1989-06-28
Active compounds for use in the treatment of tumors
AU4479889A
(en)
1990-08-09
Renin-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof
AU664101B2
(en)
1995-11-02
Novel phospholipid derivatives
AU6206486A
(en)
1987-03-05
P-acylaminobenzamides
EP0190860A3
(en)
1987-06-03
6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
AU3406089A
(en)
1989-11-09
Novel strobilurine derivatives, their preparation and their use
AU7111587A
(en)
1987-10-08
Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
AU4266089A
(en)
1990-04-12
3-aryloxymethyl-cephalosporin derivatives, their preparation and their medical use
AU3114189A
(en)
1989-09-28
2-imidazolylmethyl-1,3-dioxolanyl methylthiophenyl carbamate derivatives and their use as antineoplastic agents
AU4096889A
(en)
1990-03-08
The use of lactam derivatives in the treatment of depression
AU609337B2
(en)
1991-04-26
Tissue plasminogen activator (t-pa) muteins and processes for the preparation thereof
AU7554687A
(en)
1988-01-14
Modified tissue plasminogen activator
AU3724389A
(en)
1990-01-04
Modified rhodomycins, processes for their preparation and their use
None